| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |